MedTrace Logo

Smoking Cessation for Depression and Anxiety Treatment

NCT02002858 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-07-07

No results posted yet for this study

Summary

The primary aim of this research study is to enhance smoking cessation outcome among smokers with elevated anxiety and depression. We are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation, and anxiety and depression management treatment program (SDAT). Both treatments also utilize nicotine replacement therapy.

Conditions

  • Smoking
  • Anxiety Disorders
  • Depression Disorders

Interventions

DRUG

Nicotine Patch

BEHAVIORAL

Depression and Anxiety Smoking Cessation Treatment

Cognitive-behavioral treatment program that blends smoking cessation, anxiety, and depression management/reduction treatment strategies

BEHAVIORAL

Educational-Support Psychotherapy

Educational-based psychotherapy and standard smoking cessation treatment program

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Houston

    lead OTHER

Principal Investigators

  • Michael J Zvolensky, Ph.D. · University of Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-11-30
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02002858 on ClinicalTrials.gov